1. Salk News. “Cannabinoids remove plaque-forming Alzheimer’s proteins from brain cells.” June 27, 2016.
2. Jadoon KA, et al. “A single dose of cannabidiol reduces blood pressure in healthy volunteers in a randomized crossover study.” JCI Insight. 2017;2(12):e93760.
3. Grochowski J. “Novel study reports marijuana users have better blood sugar control.” Am J Med. May 13, 2013.
4. Russo EB. “Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects.” Br J Pharmacol. 2011;163(7):1344-1364.
5. United States Patent Hampson, et al. 6,630,507. “Cannabinoids as antioxidants and neuroprotectants.” USPTO Patent. October 7, 2003.
6. Salk News. “Cannabinoids remove plaque-forming Alzheimer’s proteins from brain cells.” June 27, 2016.
7. Abuhasira R, et al. “Epidemiological characteristics, safety and efficacy of medical cannabis in the elderly.” Eur J intern Med. 2018;49:44-50.
8. Jadoon KA, et al. “A single dose of cannabidiol reduces blood pressure in healthy volunteers in a randomized crossover study.” JCI Insight. 2017;2(12):e93760.
9. Penner EA, et al. “The impact of marijuana use on glucose, insulin, and insulin resistance among US adults.” Am J Med. 2013;126(7):583-589.
10. Jadoon KA, et al. “A single dose of cannabidiol reduces blood pressure in healthy volunteers in a randomized crossover study.” JCI Insight. 2017;2(12):e93760.
11. Cuttler C, et al. “A naturalistic examination of the perceived effects of cannabis on negative affect.” J Affect Dis. 2018;235:198-205.
12. Assaf S, et al. “Safety and efficacy of medical cannabis oil for behavioral and psychological symptoms of dementia: An-open label, add-on, pilot study.” J Alzheimer’s Dis. 2016;51(1):15 19.
13. Rajan TS, et al. “Cannabidiol activates neuronal precursor genes in human gingival mesenchymal stromal cells.” J Cell Biochem. 2017;118(6):1531-1546.
14. Vigil JM, et al. “Effectiveness of raw, natural medical cannabis flower for treating insomnia under naturalistic conditions.” Medicines. 2018;5(3):75.
13. Gorzo AB, et al. “A chronic low dose of Δ9 — tetrahydrocannabinol (THC) restores cognitive function in old mice.” Nature Med. 2017;23:782-787.
14. Jadoon KA, et al. “Efficacy and safety of cannabidiol and tetrahydrocannabivarin on glycemic and lipid parameters in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled, parallel group pilot study.” Diabetes Care. 2016;39(10):1777-1786.
15. Crean RD, et al. “An evidence based review of acute and long-term effects of cannabis use on executive cognitive functions.” J Addict Med. 2011;5(1):1-8.
16. Rakavashisth TB, et al. “Decreased prevalence of diabetes in marijuana users: Cross-sectional data from the National Health and Nutrition Examination Surgery (NHANES) III.” BMJ Open. 2012;2:e000494.
17. Ibid.
18. Vigil JM, et al. “Effectiveness of raw, natural medical cannabis flower for treating insomnia under naturalistic conditions.” Medicines. 2018;5(3):75.
19. Gorzo AB, et al. “A chronic low dose of Δ9 — tetrahydrocannabinol (THC) restores cognitive function in old mice.” Nature Med. 2017;23:782-787.
20. Jadoon KA, et al. “Efficacy and safety of cannabidiol and tetrahydrocannabivarin on glycemic and lipid parameters in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled, parallel group pilot study.” Diabetes Care. 2016.
21. Scripps Research. (2006, August 9). Marijuana’s active ingredient shown to inhibit primary marker of Alzheimer’s disease [News release]. Retrieved from: https://www.scripps.edu/news-and-events/press-room/2006/080906.html